Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review

Erlotinib is among the oral EGFR-tyrosine kinase inhibitors used to treat non-small cell lung cancer. The common side effects of erlotinib include acne form rash and diarrhea. Eyelash trichomegaly and alterations of scalp hair are rarely observed symptoms. In the present study, we report changes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hua, Zhang, Hongmei, Zhang, Tongmei, Wang, Qunhui, Hu, Fanbin, Li, Baolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998076/
https://www.ncbi.nlm.nih.gov/pubmed/27588051
http://dx.doi.org/10.3892/etm.2016.3460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998076/
https://www.ncbi.nlm.nih.gov/pubmed/27588051
http://dx.doi.org/10.3892/etm.2016.3460

Ejemplares similares